Clinical Trial Detail

NCT ID NCT03278405
Title Avelumab in G3 NEC (NET-001)
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Sunnybrook Health Sciences Centre
Indications

gastrointestinal neuroendocrine tumor

pulmonary neuroendocrine tumor

Therapies

Avelumab

Age Groups: adult senior

No variant requirements are available.